Section Arrow
BNTX.NASDAQ
- BioNTech SE American Depositary Share
Quotes are at least 15-min delayed:2026/09/18 17:17 EDT
After Hours
Last
 96.44
+0.38 (+0.40%)
Bid
95.95
Ask
98
High 97 
Low 95.95 
Volume 40.19K 
Regular Hours (Closed)
Last
 96.06
-2.6 (-2.64%)
Day High 
99.25 
Prev. Close
98.66 
1-M High
120.33 
Volume 
1.15M 
Bid
95.95
Ask
98
Day Low
95.71 
Open
98.81 
1-M Low
91.01 
Market Cap 
24.78B 
Currency 美元 
P/E -- 
%Yield 2.22 
10-SMA 98.66 
20-SMA 103.72 
50-SMA 97.07 
52-W High 124 
52-W Low 79.52 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-6.71/-8.19
Enterprise Value
25.00B
Balance Sheet
Book Value Per Share
81.62
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
2.87B
Operating Revenue Per Share
27.89
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
RXRXRecursion Pharmaceuticals3.83+0.29+8.19%-- 
After Hours 3.79 -0.04 -1.04%
TCRTAlaunos Therapeutics Inc.1.2-0.4-25.00%-- 
After Hours 1.3102 +0.1102 +9.18%
ROIVRoivant Sciences Ltd39.77-0.21-0.53%-- 
After Hours 39.2726 -0.4974 -1.25%
SLXNSilexion Therapeutics Corp.0.4355+0.0555+14.61%-- 
After Hours 0.4463 +0.0108 +2.48%
IOVAIovance Biotherapeutics10.25+0.23+2.30%-- 
After Hours 10.25 0 0.00%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.